低危急性亚段肺栓塞成人无抗凝监测的患病率与适用性
这项回顾性队列研究纳入美国21家社区医院2017年至2021年的666例急性亚段肺栓塞门诊患者,其中229例为低危特征。低危组中仅1例(0.4% [95%CI, 0.01%-2.4%])接受结构监测且90天无后遗症;按改良CHEST标准15.3%符合监测条件,按更严格标准(年龄<65岁且栓塞≤1个)仅6.6%符合。结论提示符合监测条件的低危患者比例有限,且即使符合条件,实际接受监测者极少。
要点
- 低危亚段肺栓塞门诊患者中,仅0.4%(95%CI 0.01%-2.4%)实际接受结构监测,90天无后遗症。
- 按改良CHEST标准(排除高危特征或右心室功能不全),15.3%低危组患者符合监测条件。
- 按更严格标准(年龄<65岁且栓塞≤1个),仅6.6%低危组患者符合监测条件。
- 低危组中仅6例(2.6%)初始未接受抗凝治疗。
- CHEST指南建议对特定门诊患者可考虑结构监测,但实际应用率极低。
适用人群与场景
- 美国21家社区医院(Kaiser Permanente Northern California)2017年1月1日至2021年12月31日的成人急性亚段肺栓塞门诊患者。
- 排除有需住院的合并诊断、非低危生命体征(收缩压<90 mm Hg、脉搏≥110次/分或外周皮肤脉搏血氧饱和度≤92%)、诊断前使用抗凝药或接受临终关怀的患者。
诊断标准与关键阈值
- CHEST指南标准(2016和2021):对无活动性癌症、深静脉血栓、心肺储备受损、明显症状或静脉血栓复发风险增高的特定门诊亚段肺栓塞患者,建议使用结构监测而不抗凝。
- 改良CHEST标准:排除具有较高风险特征或右心室功能不全的患者。
- 更严格标准:年龄<65岁且栓塞数量≤1个。
研究设计与关键结果
- 回顾性队列研究,纳入666例急性亚段肺栓塞门诊患者,其中229例具有低危特征。
- 低危组中位年龄58岁(IQR 42-68),男性120例(52.4%),非西班牙裔白人128例(55.9%)。
- 低危组中6例(2.6%)初始未接受抗凝治疗。
- 低危组中仅1例(0.4% [95%CI, 0.01%-2.4%])接受结构监测,90天无后遗症。
- 按改良CHEST标准,35例(低危组的15.3%,全队列的5.3%)符合监测条件。
- 按更严格标准,15例(低危组的6.6%,全队列的2.3%)符合监测条件。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 尽管CHEST指南建议对特定低危亚段肺栓塞门诊患者可考虑结构监测,但本研究中符合监测条件的患者比例有限,且实际接受监测者极少。
- 作者认为,若未来试验发现监测安全有效,将监测推广至临床实践可能需要不止被动扩散。
指南或共识出处
- 2016年和2021年美国胸科医师学会(CHEST)指南及专家小组报告。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Approximately 8% of acute pulmonary emboli are confined to the subsegmental arteries. The 2016 and 2021 American College of Chest Physicians (CHEST) guidelines and expert panel reports suggest the use of structured surveillance without anticoagulation for select ambulatory patients with subsegmental pulmonary embolism who do not have active cancer, deep vein thrombosis, impaired cardiopulmonary reserve, marked symptoms, or increased risk of recurrent venous thromboembolism; however, guideline uptake in community practice is unknown, as is the proportion of outpatients eligible for surveillance.
OBJECTIVE: To describe the prevalence of surveillance among outpatients with acute subsegmental pulmonary embolism and to estimate the proportion of patients eligible for structured surveillance using modified CHEST criteria.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study was conducted across 21 US community hospitals in the Kaiser Permanente Northern California integrated health system from January 1, 2017, to December 31, 2021. Adult outpatients with acute subsegmental pulmonary embolism were included. Patients with the following higher-risk characteristics were excluded: codiagnoses requiring hospitalization, non-low-risk vital signs (ie, systolic blood pressure <90 mm Hg, pulse ≥110 bpm, or peripheral cutaneous pulse oximetry ≤92%), prediagnosis anticoagulant use, or hospice care. Data analysis was performed from November 2022 to February 2023.
MAIN OUTCOMES AND MEASURES: The main outcomes were the (1) prevalence of surveillance and (2) eligibility for surveillance using 2 sets of criteria: the CHEST criteria modified by excluding patients with higher-risk characteristics or right ventricular dysfunction and a stricter set of criteria requiring age younger than 65 years and no more than 1 embolus. The prevalence of structured surveillance was calculated and the proportion of patients eligible for surveillance was estimated.
RESULTS: Of the 666 outpatients with acute subsegmental pulmonary embolism included in this study, 229 with lower-risk characteristics were examined. Their median age was 58 (IQR, 42-68) years; more than half were men (120 [52.4%]) and self-identified as non-Hispanic White (128 [55.9%]). Six patients (2.6%) were initially not treated with anticoagulants. Among the lower-risk cohort, only 1 patient (0.4% [95% CI, 0.01%-2.4%]) underwent structured surveillance, without 90-day sequelae. Thirty-five patients (15.3% of the lower-risk group and 5.3% of the full cohort) were surveillance eligible using modified CHEST criteria. Fifteen patients (6.6% of the lower-risk group and 2.3% of the full cohort) were surveillance eligible using stricter criteria.
CONCLUSIONS AND RELEVANCE: In this cohort study of lower-risk outpatients with subsegmental pulmonary embolism, few were eligible for structured surveillance, and only a small proportion of eligible patients underwent surveillance despite the CHEST guideline. If forthcoming trials find surveillance safe and effective, substantial uptake into clinical practice may require more than passive diffusion.
参考来源
- Rouleau SG, Balasubramanian MJ, Huang J, et al. Prevalence of and Eligibility for Surveillance Without Anticoagulation Among Adults With Lower-Risk Acute Subsegmental Pulmonary Embolism. JAMA Netw Open. 2023. PMID: 37531107. doi:10.1001/jamanetworkopen.2023.26898
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。